Featured Archives - OMNY Health

We are thrilled to announce that OMNY Health has been named a winner in the prestigious Fierce Healthcare Innovation Awards for our groundbreaking work in Clinical Information Management!

This recognition from Fierce Healthcare, a leading voice at the intersection of healthcare, business, and policy, celebrates the organizations that are driving improvements and truly transforming the industry.

OMNY Health was honored specifically for our innovative work on Unstructured Clinical Notes, demonstrating our unwavering commitment to unlocking the full potential of real-world data to advance research, power AI, and ultimately, improve patient care.

OMNY’s Eric Lavin, SVP Commercial, and Dr. Mitesh Rao, CEO at the Fierce Innovation Awards in New York City

Unlocking the Hidden Context of Care

The majority of critical patient context is often buried within unstructured data inside the Electronic Health Record (EHR). This context includes the nuances of a diagnosis, the challenges of a treatment plan, and the social factors affecting a patient’s journey, such as physician notes, discharge summaries, and clinical reports. This information is notoriously difficult to access, integrate, and utilize at scale.

Our ground-breaking solution tackles this challenge head-on. OMNY Health’s platform transforms billions of these complex, siloed, unstructured clinical notes into high-quality, regulatory-grade, and AI-ready datasets. By linking this deep, contextual information with structured clinical data, we provide a holistic, longitudinal view of the patient experience.

This capability is essential for:

Fueling Responsible AI: Providing clean, unbiased, and comprehensive datasets to train next-generation clinical and operational AI models.

Accelerating Research: Giving life sciences and healthcare researchers the necessary context to understand treatment efficacy, patient subpopulations, and complex disease progression.

Driving Health Equity: Ensuring that data used for research and development is truly representative of the national population, including diverse geographies, ethnicities, and care settings.

A Mission Confirmed

This award is a powerful validation of our democratic approach to healthcare data, which focuses on partnering directly with provider organizations to create a nationally representative “living data layer.”

“To be recognized by Fierce Healthcare for our work in Clinical Information Management is a tremendous honor and underscores the criticality of solving the unstructured data problem,” said Mitesh Rao, M.D., CEO and co-founder of OMNY Health. “The true voice of the patient and the context of their care often reside in those notes. By making this data accessible and usable, we are giving researchers, developers, and health systems the fuel they need to deliver on the promise of precision medicine and responsible AI.”

The Future of Real-World Data

At OMNY Health, we believe that clean, usable, and representative data is the foundation of a better healthcare future. We are proud to stand among the industry’s most innovative companies and remain committed to expanding our platform to help our partners accelerate discovery and improve outcomes for millions of patients across the nation.

Learn more about the awards and our category win on the official Fierce Healthcare Innovation Awards page.

Discover how OMNY Health is transforming real-world data for your organization at omnyhealth.com.

By Danae A. Black, Amanda Mummert, Amanda G. Althoff, and Lawrence Rasouliyan | OMNY Health

Tuberculosis (TB) has been a continuous public health challenge in the United States. Even though there are numerous screening and treatment options available, the burden of active TB disease still rises. Almost 80% of TB cases reactivate latent TB infection (LTBI). Timely identification of at-risk individuals and understanding their screening patterns is primarily important to reduce disparities in care.

Building the Study: From EHR Data to Insights

Our research team at OMNY Health conducted a retrospective, observational study using the OMNY Health Real-World Data Platform (2020–2024), which integrates electronic health records (EHRs) from multiple U.S. health systems. The goal was to describe individuals diagnosed with respiratory TB and evaluate patterns of TB screening and latent TB diagnosis before the onset of active TB disease.

Study Design and Methods

OMNY Health dataset identified the patients with respiratory TB (ICD-10-CM: A15). The earliest date of respiratory TB diagnosis was considered the index date. Demographic characteristics and social determinants of health (SDoH) were summarized at the index date or during the pre-index period.

Utilization of TB screening procedures (CPT: 86480, 86481, 86580; ICD-10-CM: Z11.1) or diagnosis of latent TB (ICD-10-CM: Z22.7, Z86.15) was evaluated during the pre-index period. Descriptive statistics were reported for all variables of interest.

Results: Identifying Patterns in Screening and Latent TB

Between the years 2020-2024, total 6,538 cases of respiratory TB were diagnosed. Among these cases, 238 had a latent TB diagnosis code before the index date and 20% showed evidence of TB screening prior to diagnosis.

TB testing was significantly higher among females and younger people, whereas it was lower among nonwhite and Hispanic groups. There had been more latent TB recorded among Hispanic individuals. This is consistent with high-risk profiles often seen among overseas-born populations or the ones travelling to counties where it is common.

Approximately 5% of the population had data available on social health determinants, which revealed certain transportation and education barriers impeding prevention measures or treatment adherence.

Figure 1. TB Prevention Pathway

Figure 2. Study Population Demographics Characteristics, by TB Status

Figure 3. Percentage of Affirmative Responses Across Social Determinants of Health Domains, by TB Status

Why It Matters: Addressing Gaps in TB Prevention

The study emphasizes early detection and screening to better prevent TB reactivation. The differences identified in screening rates indicate that demographic and social factors play a vital role to prevent TB. More targeted interventions can be developed to reduce inequities and improve outcomes if proper identification of populations (with limited access to screening and care) is done.

Looking Ahead

OMNY Health leverages real-world EHR data to better understand patient journeys enhancing preventive care. Future research is aimed to expand the SDoH integration into predictive modeling and public health decision-making. This will be helpful to bridge the gap between data and actionable outcomes.

References

Centers for Disease Control and Prevention. National Data: Reported Tuberculosis in the United States, 2023. Reported Tuberculosis in the United States, 2023. 2024 Nov 7. Accessed February 10, 2025. https://www.cdc.gov/tb-surveillance-report-2023/summary/national.html

US Preventive Services Task Force. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;329(17):1487–1494. doi:10.1001/jama.2023.4899C.